This inventor holds 2 USPTO granted patents. Top assignees: Bristol-Myers Squibb, Other. Active years: 1994-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Angleur, BE (1994)
- B-4031, Angleur, BE (2000)
Company Filing History:
Years Active: 1994-2000
Title: Innovations in Medical Imaging by Jean F Desreux
Introduction
Jean F Desreux is a notable inventor based in Angleur, Belgium. He has made significant contributions to the field of medical imaging through his innovative patents. With a total of 2 patents, Desreux's work focuses on the development of advanced imaging agents that enhance diagnostic capabilities.
Latest Patents
Desreux's latest patents include "Self-assembling heteropolymetallic chelates as imaging agents" and "Metal complexes of new ligands of the formula ##STR1##." These inventions are particularly useful for medical imaging, especially in MRI applications. The compounds he developed are designed for both in vitro and in vivo diagnostics, as well as for use as radiopharmaceuticals. The coordinating groups in these compounds are capable of forming highly stable complexes with metal ions, which significantly improves imaging quality.
Career Highlights
Throughout his career, Jean F Desreux has worked with prominent companies, including Bristol-Myers Squibb. His expertise in the field has led to the creation of novel compounds that serve as effective contrast agents for MRI, particularly in the hepatobiliary system. His innovative approach has contributed to advancements in medical imaging technology.
Collaborations
Desreux has collaborated with notable individuals in the field, including Michael F Tweedle and Thomas R Wagler. These partnerships have further enhanced the development of his groundbreaking inventions.
Conclusion
Jean F Desreux's contributions to medical imaging through his innovative patents have significantly advanced the field. His work continues to impact diagnostic practices and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile